A study published last month in Nature highlighted the potential for a new personalized pancreatic cancer vaccine. The trial was tiny, just 16 patients, but it’s ...

Citigroup assumed coverage on shares of Moderna (NASDAQ:MRNA – Free Report) in a research report report published on Thursday morning, MarketBeat.com reports. The brokerage issued a neutral rating and ...

Claiming the United States was being invaded by a Venezuelan gang, President Donald Trump on Saturday invoked the Alien ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid ...

With the help of mRNA technology proven effective during the COVID era, researchers are now closer than ever to creating ...

WASHINGTON (AP) — Secretary of State Marco Rubio said Friday that South Africa’s ambassador to the United States “is no ...

President Donald Trump has slashed another grant given to the National Health Institute to study vaccine hesitancy and more ...

The new exhibition honors the healthcare workers, community members and public officials that worked to build trust in the medical community during a time of crisis and uncertainty.

Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with ...

Short sellers increased their bets against the broader healthcare sector in February vs. January, and Moderna remained the ...

Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.